As an accredited provider of continuing medical education, it is the policy of Med-CE-online.com and Educational Review Systems (ERS) to ensure balance, independence, objectivity, and scientific rigor in all of its educational programs. In accordance with this policy, faculty must disclose to the participants any significant relationships with the commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this continuing pharmaceutical education program. The intent of this disclosure is not to prevent a person with a significant financial or other relationship from participating in the planning or review of programs, but rather to provide the intended audience with information on which they can make their own judgments. It remains for the audience to determine whether the interests or relationships of planning committee members, reviewers, or cosponsors may influence the presentation with regard to exposition or conclusion.
Chad S. Boomershine, MD, PhD
Fibromyalgia and Psychoneuroimmunology Specialist
Vanderbilt Center for Integrative Health
Assistant Professor of Medicine
Division of Rheumatology and Immunology
VanderbiltUniversity
Nashville, TN, U.S.A.
Dr. Boomershine discloses that he (or his spouse) has a financial interest or other financial relationship with the manufacturer(s) of products or providers of services discussed in the presentation. He has consulting agreements, has received honoraria, and is a member is of the Speaker's Bureau of:
Forest Pharmaceuticals Inc., Pfizer, Inc., Eli Lily & Co., and Takeda Pharmaceuticals America, Inc.
He has also received research grants from Pfizer, Inc.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The JestaRx Group, Med-CE-online.com, and Educational Review Systems do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the The JestaRx Group, Med-CE-online.com, and Educational Review Systems . Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Dr. Boomershine discloses that unapproved drug use is discussed for Nucynta, Paroxetine, Cyclobenzaprine, Remeron, Trazodone, Tramadol, Fluoxetine, Elavil, Gabapentin, Modafinil, Ritalin, Focalin, Dextroamphetamines, Straterra, Mirapex, Requip, Sinement, Sodium Oxybate, Seroquel, Effexor, Nuvigil, Acetaminophen.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.